Видео с ютуба Dr Daniel Landsburg

The real-world outcomes of tisa-cel in patients with aggressive B-cell lymphoma

The real-world outcomes of tisa-cel in patients with aggressive B-cell lymphoma
The current role of SCT in LBCL in the era of novel therapies: identifying patients who may benefit

The current role of SCT in LBCL in the era of novel therapies: identifying patients who may benefit
Evaluating the role of autoSCT in patients with DLBCL who relapse after first-line therapy

Evaluating the role of autoSCT in patients with DLBCL who relapse after first-line therapy
Predictors of long-term survival in patients with DLBCL/HGBCL following autoSCT

Predictors of long-term survival in patients with DLBCL/HGBCL following autoSCT
Outcomes of patients with DLBCL following ASCT and/or CAR-T

Outcomes of patients with DLBCL following ASCT and/or CAR-T
The impact of TP53 mutations and copy number loss on survival outcomes in patients with LBCL

The impact of TP53 mutations and copy number loss on survival outcomes in patients with LBCL
POLARIX lymphoma trial debate

POLARIX lymphoma trial debate
The Bright Side: Conversations with Rabbi Yochonon Goldman featuring Daniel Landsburg, MD

The Bright Side: Conversations with Rabbi Yochonon Goldman featuring Daniel Landsburg, MD
Transplant or CAR T-cell Therapy for Lymphoma? How to Make the Choice

Transplant or CAR T-cell Therapy for Lymphoma? How to Make the Choice
Донна Стрикленд — Ускорение частиц с помощью интенсивных волоконных лазеров для медицинских приме...

Донна Стрикленд — Ускорение частиц с помощью интенсивных волоконных лазеров для медицинских приме...
Daniel M. Landis, M.D., Ph.D.

Daniel M. Landis, M.D., Ph.D.
Rabbi, Dad, Cancer Survivor | Ben's Story

Rabbi, Dad, Cancer Survivor | Ben's Story
Opening Day 1 - On Human Origins and the Future of Humanity

Opening Day 1 - On Human Origins and the Future of Humanity